Boston Scientific and Fundació Puigvert join forces for continuous innovation to treat urogenital pathologies


Fundació Puigvert, the only private monographic hospital in Spain dedicated to the diagnosis and treatment of urogenital and renal pathologies, and Boston Scientific, a leading corporation in medical technology, signed today a strategic agreement to advance jointly patient care in the Urology space.

"Our goal is to offer the best medical and surgical treatments to our patients, and we believe that Boston Scientific is an ideal partner to achieve this goal. From our side, given the volume of urological pathology we deal with on a daily basis, and the excellence and experience of our professionals, we can provide Boston Scientific with an empirical vision of unmet medical and surgical needs requiring continuous innovation", says Roger Abad, Corporate Director of the Fundació Puigvert. "This agreement is part of the new Strategic Plan 2021-2025 of the Fundació Puigvert, as we consolidate our leadership as a national and international reference center in the specialties of Urology, Nephrology, Andrology and Reproductive Medicine".

Miguel Aragón, Vice President of Urology and Pelvic Health in Europe, Middle East and Africa at Boston Scientific has pointed out that "this agreement will strengthen Fundació Puigvert specialization even further, allowing to become a lighthouse at national and international level for innovative technologies in the field of Stone, BPH and men’s health. We clearly share a common goal: to improve patient care”

The strategic agreement consists in the supply of a series of state-of-the-art medical devices, consumables and accessories for endourological procedures (minimally invasive surgical techniques: urethroscopy, cystoscopy, ureteroscopy and nephroscopy), BPH, UI, ED. In this sense, the Director of the Urology Service of the Fundació Puigvert, Dr. Joan Palou has stated that "having the latest medical technology and contributing to its development not only brings benefits to our patients, which is our main concern, but also represents a motivation for the medical and surgical teams, who look at the future of the specialty".

Science, Technology and Medicine together for innovation  

The multinational Boston Scientific and the Fundació Puigvert share the same objective: to transfer the results of scientific research to the healthcare sector in order to improve the quality of life of patients. "By working closely together, I am confident that Fundació Puigvert and Boston Scientific will be in an excellent position to innovate and strengthen excellence in patient care. We look forward offering our broad portfolio of urology solutions to increase treatment options available for Fundació Puigvert patients in the Spanish region and throughout Europe.” said Meghan Scanlon, President of Urology and Pelvic Health at Boston Scientific.

To sum up, Mr. Ramon Massaguer, General Director of Fundació Puigvert has concluded that "Fundació Puigvert is recognized nationally and internationally for pioneering and innovating in providing solutions to the needs of patients with urogenital pathologies. As we are currently implementing our new Strategic Plan, the collaboration with Boston Scientific allows us to reinforce and our leadership in Urology".

Thus, the strategic agreement combines the best of Science, Technology and Medicine to advance innovation and bring the best medical-surgical treatments to offer patients the best possible care and assistance.



Contacto Comunicación
934 169 700 ext. 4671



Hace 15 años, la Fundació adquirió y puso en marcha el Robot Da Vinci convirtiéndose en el primer centro en España en hacerlo.
Desde entonces, hemos ido alcanzando metas pioneras en este campo hasta posicionarse al frente de la cirugía robótica.